Senior Vice President
Wed, Aug 17, 2022
Aug 17
exercised or converted securities in APLS
5,000 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology